Enabling Equitable Access to Technology
Find out how local health authorities have addressed variations in access to glucose-sensing technology
Libre 2 sensor will be phased out at the end of August 2025.
Find out what you need to do >
Find out how local health authorities have addressed variations in access to glucose-sensing technology
Discover how initiating Continuous Glucose Monitoring (CGM) in primary care can help to improve patient health outcomes
As a registered Healthcare Professional by completing the form below an Abbott representative will contact you regarding your enquiry.
The "Yes" link below will take you to a website other than Abbott Laboratories. Links to other websites are not under the control of Abbott Laboratories, and Abbott Laboratories is not responsible for the content of such websites or any link contained in such websites. Abbott Laboratories is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement by Abbott Laboratories of the site.
Do you want to leave this page?
If you're a healthcare professional located in a different country, please select your country's website from the list of our global sites or contact your local Abbott representative for correct information about the products available in your country.
If you're not a healthcare profressional, click here to go to the FreeStyle Libre consumer website for the UK.
Stay connected